Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...

The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why ...

26 June 2025 Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after ...

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...

26 June 2025 Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal ...

17 June 2025 Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving ...

Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major ...

11 January 2022 Alexion, AstraZeneca’s rare disease group, has entered into an exclusive licensing agreement with Neurimmune ...

French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient ...

Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly ...

This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy ...

Trio have worked together for several years at different firms, bringing decades of experience in medical devices, robotics, ...